[en] Multiple primary central nervous system tumors are rarely seen in clinical practice and reported in the literature. The pathogenesis of multicentricity of primary tumors of the central nervous system still remains a debate, this pathology being found in almost two percent of reported tumor cases. Multifocal tumors are often described within the same hemisphere and supposed to be disseminated along the white matter tracts. On the opposite, multicentric tumors are found in the other hemisphere in subtentorial structures and are considered synchronous. We illustrate here the case of a young man admitted for symptoms of intracranial hypertension, diagnosed with multifocal and multicentric low-grade oligoastrocytoma with particular evolution and imagistic appearance.
Grosu, Florin; Department of Dental Medicine and Nursing, "Victor Papilian" Faculty of Medicine, "Lucian Blaga" University of Sibiu, Romania, lilianacoldea@yahoo.com
Ungureanu, Aurelian; Department of Neurology, Emergency County Hospital, Sibiu, Romania
Bianchi, Elettra ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'anatomie et cytologie pathologiques
Moscu, Bianca; Department of Neurology, Emergency County Hospital, Sibiu, Romania
Coldea, Liliana; Department of Dental Medicine and Nursing, “Victor Papilian” Faculty of Medicine, “Lucian Blaga” University of Sibiu, Romania
Stupariu, Adrian LaurenŢiu; Department of Ophthalmology, Railway Hospital, Sibiu, Romania
Pirici, Ionica; Department of Anatomy, University of Medicine and Pharmacy of Craiova, Romania
Roman-Filip, Carmen Corina; Department of Neurology, “Victor Papilian” Faculty of Medicine, “Lucian Blaga” University of Sibiu, Romania
Language :
English
Title :
Multifocal and multicentric low-grade oligoastrocytoma in a young patient.
Shakur SF, Bit-Ivan E, Watkin WG, Merrell RT, Farhat HI. Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literature. Case Rep Med, 2013, 2013: 132679.
Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol, 2009, 118(5): 599-601.
Camelo-Piragua S, Jansen M, Ganguly A, Kim JC, Louis DN, Nutt CL. Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis. Acta Neuropathol, 2010, 119(4): 509-511.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A. World Health Organization (WHO) classification of tumours of the central nervous system. 4th revised edition, International Agency for Research on Cancer (IARC) Press, Lyon, France, 2016.
Batzdorf U, Malamud N. The problem of multicentric gliomas. J Neurosurg, 1963, 20: 122-136.
Zamponi N, Rychlicki F, Ducati A, Regnicolo L, Salvolini U, Ricciuti RA. Multicentric glioma with unusual clinical presentation. Childs Nerv Syst, 2001, 17(1-2): 101-105.
Gkekas N, Vyziotis A, Dimitriadi A, Koutsonikas G, Georgakoulias N. Multifocal low-grade gliomas: adapting the optimal therapeutic management. Br J Neurosurg, 2015, 29(1): 94-96.
Salvati M, Caroli E, Orlando ER, Frati A, Artizzu S, Ferrante L. Multicentric glioma: our experience in 25 patients and critical review of the literature. Neurosurg Rev, 2003, 26(4): 275-279.
Silbergeld DL, Rostomily RC, Alvord EC Jr. The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neurooncol, 1991, 10(2): 179-185.
Terakawa Y, Yordanova YN, Tate MC, Duffau H. Surgical management of multicentric diffuse low-grade gliomas: functional and oncological outcomes: clinical article. J Neurosurg, 2013, 118(6): 1169-1175.
Gan HK, Rosenthal MA, Dowling A, Kalnins R, Algar E, Wong N, Benson A, Woods AM, Cher L. A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. Neuro Oncol, 2010, 12(5): 500-507.
